EGFR and Alzheimer disease: Signaling pathways observed to be lost in AD, with EC:Exc2, EC:Exc3, or EC:Exc5 as sources, are shown in Figure S19, and included, for example, KIT (or c-Kit) and EGF/EGFR signaling.